Loading...

Fabio Cappuccini

Title(s)Health Sciences Professor, Obstetrics and Gynecology
Phone(714) 456-7971
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Pejovic T, Pande NT, Mori M, Mhawech-Fauceglia P, Harrington C, Mongoue-Tchokote S, Dim D, Andrews C, Beck A, Tarumi Y, Djilas J, Cappuccini F, Caballero O, Huang J, Levy S, Tsiamouri A, Cain J, Bagby GC, Strausberg RL, Simpson AJ, Odunsi KO. Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes. Transl Oncol. 2009 Dec; 2(4):341-9. PMID: 19956396.
      View in: PubMed
    2. Pejovic T, Yates JE, Liu HY, Hays LE, Akkari Y, Torimaru Y, Keeble W, Rathbun RK, Rodgers WH, Bale AE, Ameziane N, Zwaan CM, Errami A, Thuillier P, Cappuccini F, Olson SB, Cain JM, Bagby GC. Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. Cancer Res. 2006 Sep 15; 66(18):9017-25. PMID: 16982743.
      View in: PubMed
    3. Calkins A, Stehman FB, Bundy B, Benda JA, Mannel RS, Seago P, Cappuccini F, Alvarez RD, Monk BJ, Maiman M. Human immunodeficiency virus testing in patients with invasive cervical carcinoma: a prospective trial of the gynecologic oncology group. Int J Gynecol Cancer. 2006 Mar-Apr; 16(2):660-3. PMID: 16681743.
      View in: PubMed
    4. Loizzi V, Chan JK, Osann K, Cappuccini F, DiSaia PJ, Berman ML. Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy. Am J Obstet Gynecol. 2003 Nov; 189(5):1301-7. PMID: 14634558.
      View in: PubMed
    5. Loizzi V, Cormio G, Loverro G, Selvaggi L, Disaia PJ, Cappuccini F. Chemoradiation: A new approach for the treatment of cervical cancer. Int J Gynecol Cancer. 2003 Sep-Oct; 13(5):580-6. PMID: 14675339.
      View in: PubMed
    6. Loizzi V, Cappuccini F, Berman ML. An unusual presentation of struma ovarii mimicking a malignant process. Obstet Gynecol. 2002 Nov; 100(5 Pt 2):1111-2. PMID: 12423825.
      View in: PubMed
    7. Tewari KS, Cappuccini F, Puthawala AA, Kuo JV, Burger RA, Monk BJ, Manetta A, Berman ML, Disaia PJ, Nisar AM. Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy. Cancer. 2001 Feb 15; 91(4):758-70. PMID: 11241244.
      View in: PubMed
    8. Tewari KS, Cappuccini F, Asrat T, Flamm BL, Carpenter SE, Disaia PJ, Quilligan EJ. Obstetric emergencies precipitated by malignant brain tumors. Am J Obstet Gynecol. 2000 May; 182(5):1215-21. PMID: 10819861.
      View in: PubMed
    9. Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF. Malignant germ cell tumors of the ovary. Obstet Gynecol. 2000 Jan; 95(1):128-33. PMID: 10636515.
      View in: PubMed
    10. Tewari K, Cappuccini F, Brewster WR, DiSaia PJ, Berman ML, Manetta A, Puthawala A, Nisar Syed AM, Kohler MF. Interstitial brachytherapy for vaginal recurrences of endometrial carcinoma. Gynecol Oncol. 1999 Sep; 74(3):416-22. PMID: 10479502.
      View in: PubMed
    11. Tewari K, Cappuccini F, Syed AM, Puthawala A, DiSaia PJ, Berman ML, Manetta A, Monk BJ. Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer. Am J Obstet Gynecol. 1999 Jul; 181(1):91-8. PMID: 10411801.
      View in: PubMed
    12. Tewari K, Cappuccini F, Rosen RB, Rosenthal J, Asrat T, Kohler MF. Relapse of acute lymphoblastic leukemia in pregnancy: survival following chemoirradiation and autologous transfer of interleukin-2-activated stem cells. Gynecol Oncol. 1999 Jul; 74(1):143-6. PMID: 10385569.
      View in: PubMed
    13. Tewari K, Cappuccini F, Balderston KD, Rose GS, Porto M, Berman ML. Pregnancy in a Jehovah's witness with cervical cancer and anemia. Gynecol Oncol. 1998 Nov; 71(2):330-2. PMID: 9826482.
      View in: PubMed
    14. Cappuccini F, Tewari K, Fuller PN, Pindur A, DiSaia PJ. Aggressive clinical behavior of a rare uterine sarcoma. Gynecol Oncol. 1998 Jul; 70(1):147-51. PMID: 9698494.
      View in: PubMed
    15. Tewari K, Cappuccini F, Gambino A, Kohler MF, Pecorelli S, DiSaia PJ. Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy. Cancer. 1998 Apr 15; 82(8):1529-34. PMID: 9554531.
      View in: PubMed
    16. Tewari K, Brewer C, Cappuccini F, Macri C, Rogers LW, Berman ML. Advanced-stage small cell carcinoma of the ovary in pregnancy: long-term survival after surgical debulking and multiagent chemotherapy. Gynecol Oncol. 1997 Sep; 66(3):531-4. PMID: 9299272.
      View in: PubMed
    17. Cappuccini F, Tewari K, Rogers LW, DiSaia PJ. Extramammary Paget's disease of the vulva: metastases to the bone marrow in the absence of an underlying adenocarcinoma--case report and literature review. Gynecol Oncol. 1997 Jul; 66(1):146-50. PMID: 9234936.
      View in: PubMed
    18. DiSaia PJ, Dorion GE, Cappuccini F, Carpenter PM. A report of two cases of recurrent Paget's disease of the vulva in a split-thickness graft and its possible pathogenesis-labeled "retrodissemination". Gynecol Oncol. 1995 Apr; 57(1):109-12. PMID: 7705692.
      View in: PubMed
    19. Cappuccini F, Lucci JA, Dett CA, Gatanaga M, Ininns EK, Gatanaga T, Yamamoto RS, Manetta A, DiSaia PJ, Granger GA. Trafficking of syngeneic murine lymphokine activated killer T cells following intraperitoneal administration in normal and tumor bearing mice. Gynecol Oncol. 1992 Aug; 46(2):163-9. PMID: 1500017.
      View in: PubMed
    20. Lucci JA, Manetta A, Cappuccini F, Ininns EK, Dett CA, DiSaia P, Yamamoto RS, Berman ML, Soopikian J, Granger GA. Immunotherapy of ovarian cancer. II. In vitro generation and characterization of lymphokine-activated killer T cells from the peripheral blood of recurrent ovarian cancer patients. Gynecol Oncol. 1992 May; 45(2):129-35. PMID: 1592279.
      View in: PubMed
    21. Ininns EK, Gatanaga M, Cappuccini F, Dett CA, Yamamoto RS, Granger GA, Gatanaga T. Growth of the endometrial adenocarcinoma cell line AN3 CA is modulated by tumor necrosis factor and its receptor is up-regulated by estrogen in vitro. Endocrinology. 1992 Apr; 130(4):1852-6. PMID: 1312427.
      View in: PubMed
    22. Gatanaga T, Hwang CD, Gatanaga M, Cappuccini F, Yamamoto RS, Granger GA. The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro. Cell Immunol. 1991 Nov; 138(1):1-10. PMID: 1655285.
      View in: PubMed
    23. Cappuccini F, Yamamoto RS, DiSaia PJ, Grosen EA, Gatanaga M, Lucci JA, Ininns EK, Gatanaga T, Granger GA. Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer. Lymphokine Cytokine Res. 1991 Jun; 10(3):225-9. PMID: 1653048.
      View in: PubMed
    24. Dett CA, Gatanaga M, Ininns EK, Cappuccini F, Yamamoto RS, Granger GA, Gatanaga T. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro. J Immunol. 1991 Mar 01; 146(5):1522-6. PMID: 1847164.
      View in: PubMed
    25. Gatanaga T, Hwang CD, Kohr W, Cappuccini F, Lucci JA, Jeffes EW, Lentz R, Tomich J, Yamamoto RS, Granger GA. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc Natl Acad Sci U S A. 1990 Nov; 87(22):8781-4. PMID: 2174164.
      View in: PubMed